Related references
Note: Only part of the references are listed.Future Treatment Options in Systemic Sclerosis-Potential Targets and Ongoing Clinical Trials
Anna Bohdziewicz et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Zibotentan in systemic sclerosis-associated chronic kidney disease: a phase II randomised placebo-controlled trial
Edward P. Stern et al.
ARTHRITIS RESEARCH & THERAPY (2022)
Insights into the knowledge of complex diseases: Environmental infectious/ toxic agents as potential etiopathogenetic factors of systemic sclerosis
Clodoveo Ferri et al.
JOURNAL OF AUTOIMMUNITY (2021)
The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort
Maria-Grazia Lazzaroni et al.
RHEUMATOLOGY (2021)
Management of Endothelial Dysfunction in Systemic Sclerosis: Current and Developing Strategies
Djulio Cesar Zanin-Silva et al.
FRONTIERS IN MEDICINE (2021)
Gastric antral vascular ectasia in systemic sclerosis: Association with anti-RNA polymerase III and negative anti-nuclear antibodies
Naomi Serling-Boyd et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2020)
Contribution of Predictive and Prognostic Biomarkers to Clinical Research on Chronic Kidney Disease
Michele Provenzano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Potential Biomarkers in Systemic Sclerosis: A Literature Review and Update
Akira Utsunomiya et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Renal Involvement in Systemic Sclerosis: An Update
Magdalena Chrabaszcz et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2020)
Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA Registry
Zdenka Hruskova et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2019)
Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort
Wanlong Wu et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Pulmonary Manifestations of Systemic Sclerosis and Mixed Connective Tissue Disease
Apostolos Perelas et al.
CLINICS IN CHEST MEDICINE (2019)
Therapy of scleroderma renal crisis: State of the art
Elisabetta Zanatta et al.
AUTOIMMUNITY REVIEWS (2018)
Treatment Algorithms for Systemic Sclerosis According to Experts
Andreu Fernandez-Codina et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Kidney transplantation in patients with systemic sclerosis: a nationwide multicentre study
Dominique Bertrand et al.
TRANSPLANT INTERNATIONAL (2017)
Fifteen-Year Analysis of Deceased Kidney Donation: A Single Transplant Center Experience in a Region of Northern Italy
Vania Cuna et al.
MEDICAL SCIENCE MONITOR (2017)
Integration of microRNA and mRNA expression profiles in the skin of systemic sclerosis patients
Bin Zhou et al.
SCIENTIFIC REPORTS (2017)
Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)
Ariane L. Herrick et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
The Frequency of Scleroderma Renal Crisis over Time: A Metaanalysis
Matthew Turk et al.
JOURNAL OF RHEUMATOLOGY (2016)
Systemic sclerosis
Yannick Allanore et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Prevalence of Anti-RNA Polymerase III Antibodies in Systemic Sclerosis New Data From a French Cohort and a Systematic Review and Meta-Analysis
Vincent Sobanski et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Prediction of Three-Year Outcome of Renal Transplantation from Optimal Donors versus Expanded Criteria Donors
Gaetano La Manna et al.
AMERICAN JOURNAL OF NEPHROLOGY (2013)
2013 Classification Criteria for Systemic Sclerosis An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Frank van den Hoogen et al.
ARTHRITIS AND RHEUMATISM (2013)
Targeting the endothelin axis in scleroderma renal crisis: rationale and feasibility
H. Penn et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2013)
Revisiting ANCA-associated vasculitis in systemic sclerosis: clinical, serological and immunogenetic factors
Emma C. Derrett-Smith et al.
RHEUMATOLOGY (2013)
Renal disease in scleroderma: an update on evaluation, risk stratification, pathogenesis and management
Victoria K. Shanmugam et al.
CURRENT OPINION IN RHEUMATOLOGY (2012)
Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies
Muriel Elhai et al.
RHEUMATOLOGY (2012)
HLA-DRB1*0407 and*1304 Are Risk Factors for Scleroderma Renal Crisis
Binh Nguyen et al.
ARTHRITIS AND RHEUMATISM (2011)
Intermediate molecular weight proteinuria and albuminuria identify scleroderma patients with increased morbidity
B. Seiberlich et al.
CLINICAL NEPHROLOGY (2011)
Endothelin-1 expression in scleroderma renal crisis
Luc Mouthon et al.
HUMAN PATHOLOGY (2011)
End-stage kidney disease due to scleroderma-outcomes in 127 consecutive ANZDATA registry cases
Brian Siva et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort
Mandana Nikpour et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Hemodynamic Predictors of Survival in Scleroderma-related Pulmonary Arterial Hypertension
Aranzazu Campo et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Rapamycin Versus Methotrexate in Early Diffuse Systemic Sclerosis Results From a Randomized, Single-Blind Pilot Study
Tien-I Karleen Su et al.
ARTHRITIS AND RHEUMATISM (2009)
Renal biopsy findings predicting outcome in scleroderma renal crisis
Ibrahim Batal et al.
HUMAN PATHOLOGY (2009)
Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients
L. Teixeira et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Mechanisms of vascular damage in SScimplications for vascular treatment strategies
S. Guiducci et al.
RHEUMATOLOGY (2008)
Incidence and prevalence of systemic sclerosis: A systematic literature review
Helene Chifflot et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2008)
Scleroderma renal crisis: patient characteristics and long-term outcomes
H. Penn et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2007)
Predictors and risk factors for recurrent scleroderma renal crisis in the kidney allograft: Case report and review of the literature
PTT Pham et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Late recurrence of scleroderma renal crisis in a renal transplant recipient despite angiotensin II blockade
WY Cheung et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Kidney transplantation for systemic sclerosis improves survival and may modulate disease activity
EM Gibney et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Mammalian target of rapamycin positively regulates collagen type I production via a phosphatidylinositol 3-kinase-independent pathway
D Shegogue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population
MD Mayes et al.
ARTHRITIS AND RHEUMATISM (2003)
Evidence-based guidelines for the use of immunologic tests: Anticentromere, Scl-70, and nucleolar antibodies
JD Reveille et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2003)
Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis
PQ Hu et al.
ARTHRITIS AND RHEUMATISM (2003)
Long-term outcomes of scleroderma renal crisis
VD Steen et al.
ANNALS OF INTERNAL MEDICINE (2000)
Share Paper
